相关实验视频

Updated: Sep 17, 2025

Analysis of Human T Cell Activity in an Allogeneic Co-Culture Setting of Pre-Treated Tumor Cells

Analysis of Human T Cell Activity in an Allogeneic Co-Culture Setting of Pre-Treated Tumor Cells

Published on: March 7, 2025

放射治疗通过通过LRRC8A/C体积调节的离子通道通过cGAMP转移增强了抗癌CD8 T细胞的反应

Limin Cao¹, Li Wang^1,2, Zhihong Li³

¹State Key Laboratory of Immune Response and Immunotherapy, Shanghai Institute of Immunity and Infection, University of Chinese Academy of Sciences, Chinese Academy of Sciences, Shanghai 200031, China.

Science immunology

|June 27, 2025

概括

量调节的离子通道 (VRAC) 将循环GMP-AMP (cGAMP) 从癌细胞转移到T细胞,增强抗癌免疫力. 这种cGAMP转移增强了T细胞效应器功能,为癌症治疗提供了新的策略.

科学领域:

免疫学免疫学免疫学
细胞生物学细胞生物学
分子生物学分子生物学

背景情况:

体积调节的离子通道 (VRACs) 对于细胞体积调节和宿主防御至关重要.
富含白的重复含有8A/C (LRRC8A/C) VRACs与免疫反应有关.
在癌症免疫治疗中VRACs的作用尚未完全理解.

研究的目的:

研究LRRC8A/C VRACs在抗癌免疫反应中的作用.
阐明cGAMP转移的机制及其对T细胞功能的影响.
探索向VRACs在癌症治疗中的治疗潜力.

主要方法:

利用了VRACs的遗传和药理抑制.
通过各种测试,评估了cGAMP从癌细胞转移到T细胞的情况.
分析了T细胞激活,增殖和效应器功能 (例如,细胞因子的产生,细胞毒性).
研究了TCR信号,PI (4,5) P2和ROS在VRAC门中的作用.

主要成果:

LRRC8A/C VRACs促进cGAMP从被照射的癌细胞转移到CD4和CD8T细胞.
TCR信号,PI,4,5,P2和ROS是VRAC通道开放的关键调节器.
cGAMP转移激活T细胞中的STING信号,导致干扰素α/β的产生和增强的CD8T细胞效应因子功能 (大酶,IFN-γ).
抑制CD39和ENPP1可以增强细胞外cGAMP和ATP,促进VRAC介导的CD8T细胞的抗癌活性.

结论:

由VRAC介导的cGAMP转移到T细胞是增强抗癌免疫力的关键机制.
向VRACs和调节细胞外核酸水平是改善癌症免疫治疗结果的有希望的策略.

更多相关视频

Tumor Transplantation for Assessing the Dynamics of Tumor-Infiltrating CD8+ T Cells in Mice

Tumor Transplantation for Assessing the Dynamics of Tumor-Infiltrating CD8+ T Cells in Mice

Published on: June 12, 2021

Generation of CAR T Cells for Adoptive Therapy in the Context of Glioblastoma Standard of Care

Generation of CAR T Cells for Adoptive Therapy in the Context of Glioblastoma Standard of Care

Published on: February 16, 2015

相关概念视频

Tumor Immunotherapy

Tumor Immunotherapy

Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.

Targeted Cancer Therapies

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...

Cytotoxic T Cells-mediated Immune Response

Cytotoxic T Cells-mediated Immune Response

Cytotoxic T cells are a vital component of the immune system. They have the remarkable ability to identify and target antigens on infected or abnormal cells. These antigens often originate from intracellular pathogens such as viruses or abnormal proteins cancer cells produce.
Immunological surveillance is the ability of immune cells to monitor and eliminate infected cells with intracellular pathogens, neoplastically transformed cells, and cells with non-self antigens. Cytotoxic T cells and NK...